Table 1.
Clinical outcomes and patient costs* for the clinical and economic review
| Clinical outcomes for clinical review | |||
|---|---|---|---|
| Outcome category | Outcome indicator |
||
| Sought | Identified | ||
| Earlier diagnosis | Disease severity at diagnosis - microbiology | smear positivity among bacteriologically-confirmed TB patients; smear grade; Xpert cycle threshold values; culture grade/colonies; time to culture positivity | smear positivity among bacteriologically-confirmed TB patients; smear grade |
| Disease severity at diagnosis - radiology | CXR severity score/grading | - | |
| Disease severity at diagnosis - anthropometric | body mass index | - | |
| Earlier diagnosis and linkage to care |
Time to first contact with health services | duration from start of symptoms to first contact with health services | duration from start of symptoms to first contact with health services |
| Time to diagnosis | duration from start of symptoms to diagnosis | duration from start of symptoms to diagnosis | |
| Time to treatment start | duration from start of symptoms to treatment start; time between diagnosis and treatment start | duration from start of symptoms to treatment start; time between diagnosis and treatment start | |
| Pre-treatment loss to follow-up | lost to follow-up between diagnosis and treatment start | lost to follow-up between diagnosis and treatment start | |
| Treatment | Treatment outcomes at treatment end | treatment success (cure and completion); lost to follow-up | treatment success (cure and completion); lost to follow-up |
| Disease outcome at treatment end - morbidity | body mass index; lung function test results; TB recurrence | - | |
| Deaths | Mortality among screened and unscreened groups | all-cause mortality; TB-specific mortality | all-cause mortality |
| Case fatality among diagnosed TB patients | all-cause case fatality; TB-specific case fatality | - | |
| Case fatality among treated TB patients | all-cause case fatality; TB-specific case fatality | all-cause case fatality; TB-specific case fatality | |
| Patient costs* for economic review | |||
| Outcome category | Outcome - cost input | ||
| Pre-diagnosis | Costs before TB diagnosis | Direct medical - consultation/administration fees; drugs (TB, other); hospitalisation; laboratory investigations, radiology investigations, other investigations Direct non-medical costs - transport, food, accommodation, nutritional supplements, childcare Indirect - productivity loss |
|
| Diagnosis | Costs during TB diagnosis | ||
| Pre-treatment | Costs before TB treatment May include pre-diagnosis and diagnosis costs |
||
| Treatment | Costs during TB treatment | ||
| Entire illness period | Costs during the illness period reported in the study | ||
| Catastrophic cost | Prevalence | proportion of total cost for TB care >20% of annual household income | |
*costs incurred by TB patients and their households